Premium Information is available for this item - Upgrade for $1 a day
6505-01-238-5627
Usp Cephalothin For Injection
6505012385627 012385627 SEFFIN NDC00173-0369-32
INC: 66667 Cephalothin For Injection
January 2023
6
Marketplace 6505-01-238-5627
Request a Quotation from participating marketplace vendors
Related Documents 6505-01-238-5627 5+ Documents (More...)
/fsg-65/fsc-6505/us 6505-01-238-5627 Usp Cephalothin For Injection 6505012385627 Injection 6505012385627
Usp Cephalothin For Injection 6505012385627 Injection 6505012385627 For Injection 6505012385627
Usp Cephalothin For Injection 6505012385627 www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-238-5627
Usp Cephalothin For Injection 6505012385627 6505190027059 https Cephalothin For Injection 6505012385627
Usp Cephalothin For Injection 6505012385627 Injection 6505012385627 www.nsnlookup.com / https https
fsc-6505/br 6505-19-001-0600 Cephalothin For Injection 6505190010600 Cephalothin For Injection 6505012385627
Usp Cephalothin For Injection 6505012385627 Cephalothin For Injection 6505190010600 6505012385627
fsg-65/fsc-6505/us 6505-01-012-9332 Contains 10 Ea00000000010EA NATO Stock Numbers Related to 6505-01-238-5627
Usp Cephalothin For Injection 6505012385627 NATO Stock Numbers Related to 6505-01-238-5627 https
6505013089434 9434 Usp Cephalothin For Injection 6505013089434 https Cephalothin For Injection 6505012385627
Restrictions 6505-01-238-5627
6505-01-238-5627 is a Usp Cephalothin For Injection that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. This item does not contain a precious metal.
Import and Export 6505-01-238-5627
- Schedule B
- Subscribe to View Schedule B
- HTS Code
- Subscribe to View HTS Code
End Users 6505-01-238-5627
- MOE Rule:
- V542
- Effective Date:
- 1 Apr 1991
Approved Sources 6505-01-238-5627
- Part Number
- Manufacturer
- Status
- NDC00173-0369-32
- Manufacturer
- 34006 - Glaxo Wellcome Inc (Active)
- Primary Buy
- Primary Buy
- SEFFIN
- 34006 - Glaxo Wellcome Inc (Active)
- Incomplete Secondary Reference
- Incomplete Secondary Reference
Datasheet 6505-01-238-5627
- Characteristic
- Specifications
- FIIG
- Specifications
- A34300
- Active Medicament Medicinal Strength [AKJA]
- 2.000 Grams Cephalothin Equivalent
- Physical Form [AGXW]
- Powder
- Administration [CSGS]
- Intravenous
- Primary Container Type [CQCT]
- Bottle, Infusion
- Primary Container Content Quantity [CRLK]
- 2 Grams Of Active Ingredient
- Total Primary Container Quantity [CSCW]
- 100
- Secondary Container Type [CQGK]
- Tray
- Primary Container Quantity Per Secondary Container [CRXL]
- 10 Tray
- Total Secondary Container Quantity [CSCX]
- 10
- Special Features [FEAT]
- Ea Infusion Bottle Has A 100 Ml Capacity
- Supplementary Features [SUPP]
- Medsep Item For Dod,Glaxo Inc
Management Data 6505-01-238-5627
- Effective Date
- Organization
- Unit of Issue
- Unit Price
- Qty Unit Pack
- Unit of Issue
- Mar 1987
- Veterans Administration (VA)
- PG
- Subscribe
- PG
- MOE
- USC
- Code
- Statement
- Order of Use
- Jump To Code
- Qty Per Assy
- UOM
- Technical Document
- Quantative Expression
- Code
- Veterans Administration (VA)
- V
- K
- U/I Contains 10 Ea
- 00000000010EA
- K
Similar Supply Items to 6505-01-238-5627
Freight Information 6505-01-238-5627
6505-01-238-5627 has freight characteristics managed by the Bonneville Power Administration.. 6505-01-238-5627 has a variance between NMFC and UFC when transported by rail and the description should be consulted.